Biocon Delivers Solid Q1 FY27 Results Driven by 17percentage Growth in Biopharma Revenu
Bengaluru, Aug 6: Biocon Limited, an innovation-led global biopharmaceuticals company, announced its consolidated financial results for the fiscal first quarter ended June 30, 2026. FINANCIAL PERFORMANCE Consolidated operating revenue increased 10% YoY to Rs 4,336 crore, driven by strong growth in the Biopharma business. Biopharma revenue grew 17% YoY, driven by momentum from recent biosimilar […]
Biocon Delivers Solid Q1 FY27 Results Driven by 17percentage Growth in Biopharma Revenu Read More »